论文部分内容阅读
目的:探讨诺舒(NovaSure)阻抗控制子宫内膜切除系统治疗异常子宫出血的可行性。方法:选择2012年1~12月在医院采用诺舒治疗异常子宫出血的12例患者,术后1、3、6个月门诊随访,观察治疗效果及并发症。结果:12例患者手术均获成功,手术时间为82~114 s,平均(98.08±9.23)s;术中出血量为0~10 ml,平均(4.33±3.23)ml;术后有效率和闭经率较高,可有效改善贫血症状。所有患者术中及术后均未出现明显并发症。结论:诺舒操作简单且安全,疗效好,适用于多种良性疾病所致的异常子宫出血,尤其适用于有严重合并症的患者,值得临床推广。
Objective: To investigate the feasibility of NovaSure impedance-controlled endometrial ablation system in the treatment of abnormal uterine bleeding. Methods: From January to December 2012, 12 patients with abnormal uterine hemorrhage treated with Nosox in the hospital were selected and followed up at 1, 3, and 6 months after operation to observe the therapeutic effect and complications. Results: All the 12 patients were operated successfully, the operative time was 82-114 s, with an average of (98.08 ± 9.23) s; the amount of bleeding during operation was 0-10 ml (average 4.33 ± 3.23) ml; the effective rate and amenorrhea A higher rate, can effectively improve the symptoms of anemia. All patients did not show any significant intraoperative and postoperative complications. CONCLUSION: Nuosu is simple and safe in operation and has good curative effect. It is suitable for abnormal uterine bleeding caused by many benign diseases. It is especially suitable for patients with severe comorbidities and is worthy of clinical promotion.